thalidomide has been researched along with Hemangioma, Capillary in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Hemangioma, Capillary: A dull red, firm, dome-shaped hemangioma, sharply demarcated from surrounding skin, usually located on the head and neck, which grows rapidly and generally undergoes regression and involution without scarring. It is caused by proliferation of immature capillary vessels in active stroma, and is usually present at birth or occurs within the first two or three months of life. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infantile or capillary hemangioma is the most common vascular tumor of childhood." | 1.35 | Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma. ( Frei-Jones, M; Leonard, JR; McKinstry, RC; Park, TS; Perry, A; Rubin, JB, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frei-Jones, M | 1 |
| McKinstry, RC | 1 |
| Perry, A | 1 |
| Leonard, JR | 1 |
| Park, TS | 1 |
| Rubin, JB | 1 |
1 other study available for thalidomide and Hemangioma, Capillary
| Article | Year |
|---|---|
Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma.
Topics: Angiogenesis Inhibitors; Brain Neoplasms; Female; Hemangioma, Capillary; Humans; Infant, Newborn; Th | 2008 |